Precipio (PRPO) Cash from Financing Activities (2010 - 2025)
Precipio's (PRPO) quarterly Cash from Financing Activities came in at $55000.0 in Q4 2025, up 129.73% YoY from $23941.2 in Q4 2024, and down 95.49% on a QoQ basis from $1.2 million in Q3 2025.
Precipio (PRPO) Cash from Financing Activities (2010 - 2025) Analysis & Trends
Precipio (PRPO) has 16 years of Cash from Financing Activities data on file, last reported at $55000.0 in Q4 2025.
- Quarterly Cash from Financing Activities rose 129.73% year-over-year to $55000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $903000.0 (up 374.47% YoY) and the FY2025 annual result came in at $903000.0, up 374.47% from the prior year.
- Cash from Financing Activities slipped to $55000.0 in Q4 2025, from $1.2 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $15.3 million in Q2 2021 to a low of -$190000.0 in Q1 2025.
- A 5-year average of $918100.0 and a median of -$54000.0 in 2021 frame the typical range for Cash from Financing Activities.
- The widest YoY moves for Cash from Financing Activities: up 3721.74% in 2023, down 396.77% in 2023.
- Tracing PRPO's Cash from Financing Activities over 5 years: stood at -$56000.0 in 2021, then slumped by 162.5% to -$147000.0 in 2022, then gained by 14.97% to -$125000.0 in 2023, then sank by 48.0% to -$185000.0 in 2024, then jumped by 129.73% to $55000.0 in 2025.
- The last three Cash from Financing Activities figures came in at $55000.0 (Q4 2025), $1.2 million (Q3 2025), and -$181000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | -1.57 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 7.27 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 12.21 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | -144.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -214.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | -325.19 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -129.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | -317.75 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | -919.90 Mn |
| 10 | Precipio | 51.56 Mn | 48.49 Mn | 3.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 55,000.00 |
| Dec 31, 2025 | 55,000.00 |
| Sep 30, 2025 | 1.22 Mn |
| Sep 30, 2025 | 1.22 Mn |
| Jun 30, 2025 | -181,000.00 |
| Jun 30, 2025 | -181,000.00 |
| Mar 31, 2025 | -190,000.00 |
| Mar 31, 2025 | -190,000.00 |
| Dec 31, 2024 | -185,000.00 |
| Dec 31, 2024 | -185,000.00 |
| Sep 30, 2024 | -158,000.00 |
| Sep 30, 2024 | -158,000.00 |
| Jun 30, 2024 | 73,000.00 |
| Jun 30, 2024 | 73,000.00 |
| Mar 31, 2024 | -59,000.00 |
| Mar 31, 2024 | -59,000.00 |
| Dec 31, 2023 | -125,000.00 |
| Dec 31, 2023 | -125,000.00 |
| Sep 30, 2023 | -92,000.00 |
| Sep 30, 2023 | -92,000.00 |